Aberrant neurofilament protein and synaptophysin expression in malignant melanoma of the nasal cavity [5]

Histopathology

Volumn 44, Issue 2, 2004, Pages 193-195

  Coli, A ^a   Giacomini, P G ^b   Bigotti, G ^a   Ferraro, S ^b   Alessandrini, M ^b   Del Vecchio, M ^a   Massi, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN; MELAN A; NEUROFILAMENT PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S 100; SYNAPTOPHYSIN;

ADULT; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LETTER; MALE; MELANOMA; NASAL MUCOSAL MALIGNANT MELANOMA; NOSE CAVITY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSURGERY;

HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NASAL CAVITY; NEUROFILAMENT PROTEINS; NOSE NEOPLASMS; SYNAPTOPHYSIN;

EID: 1542269802     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01784.x     Document Type: Letter

References (17)

1. Enee V, Houliat T, Truilhe Y, Darrouzet V, Stoll D. Sinonasal malignant melanoma. Rev. Laryngol. Otol. Rhinol. 2000; 121; 243-250.
2. Patel SG, Prasad ML, Escrig M et al. Primary mucosal malignant melanoma of the head and neck. Head Neck 2002; 24; 247-257.
3. Joughin R, Antony Shyn O, Myrden JA. Mucosal malignant melanoma of the paranasal sinuses. Ann. Plast. Surg. 1992; 29; 353-356.
4. Going JJ, Kean DM. View from beneath - pathology in focus. Malignant melanoma of the nasal cavity. J. Laryngol. Otol. 1989; 103; 231-233.
5. Thompson AC, Morgan DA, Bradley PJ. Malignant melanoma of the nasal cavity and paranasal sinuses. Clin. Otolaryngol. 1993; 18; 34-36.
6. Regauer S, Anderhunber W, Richtig E, Schachenreiter J, Ott A, Beham A. Primary mucosal melanomas of the nasal cavity and paranasal sinuses. A clinicopathological analysis of 14 cases. APMIS 1998; 106; 403-410.
7. Corwin DJ, Gown AM. Review of selected lineage-directed antibodies useful in routinely processed tissues. Arch. Pathol. Lab. Med. 1989; 113; 645-652.
8. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29; 577-580.
9. Prasad ML, Jungbluth AA, Iversen K, Huvos AG, Busam KJ. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Am. J. Surg. Pathol. 2001; 25; 782-787.
10. Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 2000; 36; 387-402.
11. Miettinen M, Fransslla K. Immunohistochemical spectrum of malignant melanoma. The common presence of keratins. Lab. Invest. 1989; 61; 623-628.
12. Shah IA, Gani OS, Wheler L. Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi. Pathol. Res. Pract. 1997; 193; 497-502.
13. Banerjee SS, Menasce LP, Eyden BP, Brain AN. Malignant melanoma showing ganglioneuroblastic differentiation. Report of a unique case. Am. J. Surg. Pathol. 1999; 23; 582-588.
14. Kardon DE, Thompson LD. Sinonasal mucosal malignant melanoma: report of an unusual case mimicking schwannoma. Ann. Diagn. Pathol. 2000; 4; 303-307.
15. Pandey M, Mathew A, Iype EM, Sebastian P, Abraham EK, Nair KM. Primary malignant mucosal melanoma of the head and neck region: pooled analysis of 60 published cases from India and review of literature. Eur. J. Cancer Prev. 2002; 11; 3-10.
16. Gutman M. Malignant melanoma of the mucous membranes. Eur. J. Surg. Oncol. 1992; 18; 307-312.
17. Goerres GW, Stoeckli SJ, Von Schulthess GK, Steinert HC. FDG PET for mucosal malignant melanoma of the head and neck. Laryngoscope 2002; 112; 381-385.